Skip to content. | Skip to navigation

Personal tools


You are here: Home / Clinic / News


Herzlich willkommen! Bienvenue! Benvenuta! Welcome!

We are very pleased to welcome Dr. Irene Flickinger (Dipl. ECVIM-Ca Oncology), who joined the AOI Center Team on a full time basis this November 2017. She is bringing with her not only all her experience, but also the newest knowledge from the University of Vienna, where she completed the Residency in Medical Oncology. Beside this she also worked in the USA and in the UK. She was recently head of the service of Medical Oncology at the Tierspital of the University of Zurich.

We are happy to finally work with her!

New specialist at the AOI Center

Since 1st of Juli Dr. Corinne Gloor reinforces the AO-Team. Originally from Canton Aargau, she studied Veterinary Medicine in Zurich and completed the Residency in Internal Medicine at the University of Bern. She speaks fluently German, English and French. She works on Monday and Thursday at the AOI Center.

We are happy to work with her!

Development of a new canine cancer therapy

We are excited about our collaboration with Ecrins Therapeutics, a French based pharmaceutical company, and UK's leading private small animal cancer treatment center VRCC, for the development of a new antivascular drug to fight cancer in dogs. The project is backed by the transnational programme Eurostars. It starts in April 2015 and is scheduled to run for 3 years.

Press release of Ecrins Therapeutics

Superficial tumors of the cat: new research cooperation

We collaborate with the European Synchrotron Radiation Facility in Grenoble to fight specific tumors. Don't hesitate to contact us for further information:

Feline fibrosarcoma and squamous cell carcinoma: new therapeutic options

We offer new therapeutic options for these tumors. Please do not hesitate to contact us for further information: 

Superficial tumors of the dog: new immunotherapy

We apply a novel immunotherapy in the context of a clinical study in collaboration with the ETH Zürich. Don't hesitate to contact us for further information: